Jim Cramer’s Game Plan for 5 Stocks and His Take on the Market Post Iran-U.S. Ceasefire Talks

In this article, we will look at Jim Cramer’s Game Plan for 5 Stocks and His Take on the Market Post Iran-U.S. Ceasefire Talks. Please visit Jim Cramer’s Game Plan for 12 Stocks and His Take on the Market Post Iran-U.S. Ceasefire Talks, if you’d like to see the extended list and methodology behind it.

5. Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) is among the stocks on Jim Cramer’s game plan as he shared his take on the market post Iran-U.S. ceasefire talks. Cramer noted that it has become his favorite drug stock instead of Eli Lilly, as he said:

Now, my favorite drug stock reports next week, too, and that’s not Lilly anymore. It’s Johnson & Johnson. We own this one for the Charitable Trust, and I think we’re going to hear that it has the most blockbusters and the best pipeline in the industry. This is a company transformed, shedding slower, growing divisions, focusing on research that can produce lifesaving drugs. I eagerly await this one. Now, word to the wise, it’s really important. JNJ has a habit of getting hammered on the news release when it comes out in the morning, okay, and then rallying, once the conference call starts. If it gets blasted, try to get some.

Johnson & Johnson (NYSE:JNJ) develops and sells healthcare products, including pharmaceuticals and medical technologies, with treatments in immunology, oncology, neuroscience, cardiovascular care, and infectious diseases.